Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2005
11/30/2005CN1703405A Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors
11/30/2005CN1703403A Metabotropic glutamate receptor antagonists
11/30/2005CN1703401A Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1703394A Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents
11/30/2005CN1703393A Spiro compounds, medicinal compositions containing the same and intermediates of the compounds
11/30/2005CN1703259A Heterocyclic compound for stimulating or inducing hair or eyelash growth and/or for slowing down hair loss, composition containing same, and uses thereof
11/30/2005CN1703245A Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity
11/30/2005CN1703236A Use of il-2 receptor antibodies to prevent toxicity associated with amphotericin b antimycotic therapy
11/30/2005CN1703230A Antitumor agent containing lactic acid oligomer mixture
11/30/2005CN1703229A Compositions and methods for treatment of prostate and other cancers
11/30/2005CN1703228A Compounds that interact with gpcrs
11/30/2005CN1703227A Methods and compositions for treatment of neurological disorder
11/30/2005CN1703226A Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol
11/30/2005CN1703225A Combination therapy with gemcitabine and zd6126
11/30/2005CN1703224A Therapeutic treatment
11/30/2005CN1703223A Use of the quinazoline derivative zd6474 combined with gemcitabine and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
11/30/2005CN1703222A Method of using (2-imidazolin-2-ylamino) qinoxalines in the treatment of dementia and Parkinsons
11/30/2005CN1703220A Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease
11/30/2005CN1703219A Transdermal preparations comprising eperisone, tolperisone or salts thereof
11/30/2005CN1703218A Combinations of benzodithiazoles and COx-2 inhibitors for the treatment of pain
11/30/2005CN1703217A Use of epothilone derivatives for the treatment of hyperparathyroidism
11/30/2005CN1703216A Epothilone derivatives for the treatment of multiple myeloma
11/30/2005CN1703215A Stabilized pharmaceutical preparation comprising an amorphous active substance
11/30/2005CN1703214A Amino acid compositions for improving central functions
11/30/2005CN1703213A Alpha 2b 0r 2b/2c adrenoceptor agonists for the treatment of neurodegeneration
11/30/2005CN1703212A Use of a combination of dppe with other chemotherapeutic agents for the treatment of breast cancer
11/30/2005CN1703210A Formulation, which can be administered gastrointestinally, and uses thereof
11/30/2005CN1703209A Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics
11/30/2005CN1703208A EPO D+5-fu/gemcitabine
11/30/2005CN1703207A Methods for increasing bone formation using inhibitors of glycogen synthase kinase-3 betta
11/30/2005CN1703206A Plaster for the treatment of dysfunctions and disorders of nail growth
11/30/2005CN1703205A Extended, controlled-release pharmaceutical compositions using charged polymers
11/30/2005CN1703204A Stabilized pharmaceutical composition containing basic excipients
11/30/2005CN1703203A Organoleptically acceptable intraorally disintegrating compositions
11/30/2005CN1703202A Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrier
11/30/2005CN1703201A Solid particulate antifungal compositions for pharmaceutical use
11/30/2005CN1703199A Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially throug
11/30/2005CN1703198A Depot formulations of arylheterocyclic active agents in the form of a suspension
11/30/2005CN1703197A Injectable depot compositions and uses thereof
11/30/2005CN1703147A Full range nutritional supplements from plant materials and methods for their manufacture
11/30/2005CN1702070A N-benzyl acryloyl substituted tyrosine derivatives as hPPAR alpha and hPPAR gamma agonist
11/30/2005CN1702069A Alpha-piperazine substituted phenyl-propionic acid derivatives as hPPAR alpha and hPPAR gamma agonist
11/30/2005CN1702068A Alkanoyl substituted tyrosine derivatives as hPPAR alpha and hPPAR gamma agonist
11/30/2005CN1701815A Anti-caries oral compositions
11/30/2005CN1701814A F1K-1 is a receptor for vascular endothelial growth factor
11/30/2005CN1701795A Dripping pills of centella total saponin and its preparation process
11/30/2005CN1701794A Hyperlipemia treating composition
11/30/2005CN1701793A Usage of pirfenidone for treating hepatic injury and necrosis and acute lung injury
11/30/2005CN1701792A Preparation for external use on skin
11/30/2005CN1701791A Medicine for treating allergic skin disease and its preparation process
11/30/2005CN1701790A Use of non-steroidal sulphamate compound in the preparation of medicine for treating tumor
11/30/2005CN1701789A Nutrition replenisher containing sialic acid and its derivative
11/30/2005CN1701787A Application of Danshensu in preparation of medicine for treating cerebrovascular diseases
11/30/2005CN1701786A Preparation method of nonoxinol foamable composition and its quality control method
11/30/2005CN1229646C Catalytic anti-factor VIII allo-antibodies
11/30/2005CN1229502C Fermentative preparation process for cytostatics and crystal form thereof
11/30/2005CN1229501C Mixture of recombinant vaccinia vectors as poly-envelope protein vaccines for HIV
11/30/2005CN1229498C Recombinant ribonuclease proteins
11/30/2005CN1229496C Method and compositions for inducing tumor-specific cytotoxicity
11/30/2005CN1229491C Method for microbial regulation
11/30/2005CN1229388C N-terminal modified protein compositions and methods therefor
11/30/2005CN1229385C Composition for stimulating megacaryocyte growth and differentiation and process thereof
11/30/2005CN1229382C Hemisynthetic method and intermediate thereof
11/30/2005CN1229381C Macrolides compound
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/30/2005CN1229375C Nicotinic acetylcholine receptor inhibitor, its prepn. and application
11/30/2005CN1229374C Substituted bisindolylmaleimides for inhibition of cell proliferation
11/30/2005CN1229373C Piperidinee derivatives as neurokinin1 antagonists
11/30/2005CN1229371C Benzopyranyl guanidine derivtives, process for preparation thereof and pharmaceutical compositions containing them
11/30/2005CN1229370C Novel derivatives of flavones, xanthones and coumarins
11/30/2005CN1229364C Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
11/30/2005CN1229362C Bicyclic guanidine derivatives and therapeutic uses thereof
11/30/2005CN1229353C Method and compositions utilizing quinazolinones
11/30/2005CN1229351C Heterocyclic compounds and methods to treat cardiac failure and other disorders
11/30/2005CN1229350C New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
11/30/2005CN1229349C Pyridine-3-carboxylic acid derivative
11/30/2005CN1229347C Process for production of piperidine derivative fexofenadine
11/30/2005CN1229345C N-(indolcarbonyl) piperazin derivatives
11/30/2005CN1229344C Farnesyl transferase inhibitors
11/30/2005CN1229343C Chemotactic factor receptor active regulator
11/30/2005CN1229342C Omega-naphthenic base prostaglandin E2 derivatives
11/30/2005CN1229341C Method for oxidizing thioether group into sulfoxide group
11/30/2005CN1229339C Compounds inhibiting angiogenesis and tumor growth, pharmaceutical preparation containing same and pharmaceutical use thereof
11/30/2005CN1229335C Nervinolin derivatives
11/30/2005CN1229334C Inhibitors of alpha4 mediated cell adhesion
11/30/2005CN1229331C Inhibitor of monoamine uptake
11/30/2005CN1229324C Extraction process of tanshin general phenolic acid and its prepn and use
11/30/2005CN1229315C Method of converting inositol derivative in bitter buckwheat seed into its monomer and its extraction product
11/30/2005CN1229148C Adhesion preventing membrane and its preparing method
11/30/2005CN1229142C NSAID and EFGR kinase inhibitor contg. compsn. for treatment or inhibition of colonic polyps and colorectal cancer
11/30/2005CN1229141C Combination therapy of angiotension converting enzyme inhibitor and epoxy-steroidal aldosterone anatagonist for treatment of cardiovascular disease
11/30/2005CN1229140C Targeted anticarious DNA vaccine and peparation thereof
11/30/2005CN1229116C Injection of invermection for treating ox-warble myiosis
11/30/2005CN1229115C Nutritional formulation containing prebiotic substances
11/30/2005CN1229114C Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
11/30/2005CN1229113C A Pharmaceutical composition for the treatment of autoimmune diseases
11/30/2005CN1229112C Rapid onset preparation
11/30/2005CN1229111C Sustained release preparations
11/30/2005CN1229110C Ophthalmic compositions containing galactomannan polymers and borate
1 ... 4453 4454 4455 4456 4457 4458 4459 4460 4461 4462 4463 4464 4465 4466 4467 4468 4469 4470 4471 4472 4473 ... 7860